Double maintains 1 strategies that include IMVT - Immunovant, Inc.
SeekingAlpha
Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ARGX stock here.
Yahoo
Stifel analyst Alex Thompson raised the firm’s price target on Immunovant (IMVT) to $61 from $58 and keeps a Buy rating on the shares following yesterday’s topline data from the Batoclimab Myasthtenia Gravis and chronic inflammatory demyelinating polyneuropathy studies. The firm believes both studies support its thesis that IMVT-1402 is a highly-derisked asset within the growing/strategically-important fragment crystallizable receptor space. Bottom line, Stifel added that it updated its Immunova
Yahoo
Immunovant (IMVT) reported best absolute improvements with IMVT-1402 in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, and while H.C. Wainwright analyst Douglas Tsao was encouraged to see the impressive absolute improvements in MG-Activities of Daily Living, the firm acknowledges that the placebo-adjusted readout was mid-pack among FcRn inhibitors-better than nipocalimab but below argenx’s (ARGX) Vyvgart and UCB’s (UCBY) Rystiggo, the analyst tells investors. The compan
Yahoo
Immunovant's batoclimab shows strong efficacy in MG & CIDP, but shifts focus to the lead drug IMVT-1402 for these indications to induce deeper, lasting relief.
SeekingAlpha
Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.
Yahoo
Immunovant and Roivant Sciences said Wednesday their rare disease drug succeeded in a final-phase study, but the duo won't seek approval.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCK | -17.05% | $84.34B | +25.44% | 0.41% |
SMMT | -15.03% | $14.23B | +384.67% | 0.00% |
LITB | -13.08% | $36.77M | -56.14% | 0.00% |
EXC | -11.96% | $46.52B | +23.77% | 3.35% |
CBOE | -11.93% | $23.69B | +24.42% | 1.08% |
PM | -11.64% | $246.80B | +73.59% | 3.38% |
TKC | -10.17% | $5.42B | +21.01% | 3.29% |
TRVG | -9.33% | $93.53M | +35.76% | 0.00% |
GFI | -8.94% | $19.77B | +38.50% | 2.46% |
KDP | -8.64% | $46.43B | +9.57% | 2.59% |
VZ | -8.53% | $190.95B | +7.28% | 5.89% |
TEF | -7.19% | $26.30B | +6.15% | 6.71% |
COR | -7.13% | $53.93B | +14.44% | 0.76% |
UUU | -6.87% | $4.12M | +11.25% | 0.00% |
NOC | -6.73% | $74.12B | +8.63% | 1.60% |
AEP | -6.49% | $58.35B | +29.22% | 3.34% |
HUSA | -6.47% | $12.08M | -45.38% | 0.00% |
KO | -6.43% | $308.22B | +18.03% | 2.74% |
CQP | -6.39% | $31.97B | +33.68% | 4.87% |
BTCT | -6.37% | $20.20M | +17.54% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 51.05% | $5.33B | 0.35% |
IBB | 50.16% | $5.92B | 0.45% |
GNOM | 45.36% | $53.29M | 0.5% |
FBT | 42.68% | $1.08B | 0.56% |
BBH | 42.54% | $368.79M | 0.35% |
XPH | 41.63% | $156.75M | 0.35% |
PBE | 41.55% | $233.11M | 0.58% |
RSPA | 40.39% | $290.25M | 0% |
ARKG | 40.23% | $977.87M | 0.75% |
EFAA | 38.78% | $100.51M | 0% |
IWC | 38.66% | $810.14M | 0.6% |
PINK | 38.61% | $141.43M | 0.5% |
CPRJ | 38.45% | $48.46M | 0.69% |
PTH | 38.42% | $110.42M | 0.6% |
IWO | 36.84% | $10.88B | 0.24% |
ISCG | 36.43% | $654.50M | 0.06% |
KJAN | 36.16% | $318.03M | 0.79% |
VTWO | 35.94% | $10.91B | 0.07% |
QQQJ | 35.93% | $594.32M | 0.15% |
IWM | 35.80% | $64.21B | 0.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -27.70% | $195.31M | 0.85% |
TAIL | -25.09% | $86.92M | 0.59% |
BTAL | -22.65% | $404.97M | 1.43% |
ULST | -21.59% | $587.03M | 0.2% |
CLOI | -10.50% | $1.02B | 0.4% |
BUXX | -8.93% | $231.44M | 0.25% |
XHLF | -6.91% | $1.06B | 0.03% |
DBA | -6.12% | $822.16M | 0.93% |
GOVZ | -5.99% | $288.61M | 0.1% |
SPSK | -5.61% | $296.56M | 0.5% |
XONE | -5.49% | $628.76M | 0.03% |
FXY | -5.20% | $546.19M | 0.4% |
TPMN | -5.14% | $33.51M | 0.65% |
PWZ | -4.92% | $698.23M | 0.28% |
CARY | -4.85% | $347.36M | 0.8% |
AFIF | -4.77% | $135.76M | 1.11% |
PZA | -4.01% | $2.97B | 0.28% |
CTA | -3.70% | $963.19M | 0.76% |
SOYB | -3.59% | $25.81M | 0.22% |
TAXF | -3.32% | $515.52M | 0.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CANE | 0.02% | $11.05M | 0.29% |
SPTS | 0.03% | $6.00B | 0.03% |
KRBN | -0.08% | $173.49M | 0.85% |
KCCA | 0.11% | $109.47M | 0.87% |
UTWO | 0.11% | $377.34M | 0.15% |
MMIT | -0.12% | $832.86M | 0.3% |
BSMW | -0.15% | $100.61M | 0.18% |
IBTP | -0.16% | $108.59M | 0.07% |
MMIN | -0.17% | $471.66M | 0.3% |
TDTT | -0.17% | $2.38B | 0.18% |
STXT | -0.20% | $133.48M | 0.49% |
SCHO | -0.27% | $10.95B | 0.03% |
FTSD | -0.40% | $220.28M | 0.25% |
JMBS | 0.41% | $5.15B | 0.23% |
SCHP | 0.42% | $12.96B | 0.03% |
BILZ | 0.45% | $709.48M | 0.14% |
SHAG | 0.53% | $42.80M | 0.12% |
GTIP | -0.59% | $144.83M | 0.12% |
GVI | 0.59% | $3.37B | 0.2% |
HTRB | 0.61% | $2.01B | 0.29% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
APP | 0.01% | $90.08B | +283.24% | 0.00% |
UTZ | -0.01% | $1.21B | -24.20% | 1.69% |
FDP | -0.07% | $1.48B | +21.14% | 3.40% |
AQB | -0.07% | $2.67M | -65.90% | 0.00% |
RSG | 0.14% | $75.62B | +27.57% | 0.92% |
FDX | -0.16% | $58.41B | -12.98% | 2.26% |
CRDO | 0.17% | $6.82B | +88.90% | 0.00% |
CORT | 0.19% | $12.05B | +343.75% | 0.00% |
AGL | 0.21% | $1.79B | -25.86% | 0.00% |
GO | 0.24% | $1.36B | -51.24% | 0.00% |
FRO | -0.31% | $3.31B | -37.94% | 11.84% |
VTR | -0.33% | $30.09B | +60.43% | 2.65% |
WCN | 0.37% | $50.38B | +14.56% | 0.61% |
SCM | 0.38% | - | - | 11.46% |
HIHO | -0.39% | $8.12M | -11.51% | 6.50% |
CCEC | -0.40% | $1.12B | +11.47% | 3.12% |
ZCMD | 0.42% | $32.28M | -3.40% | 0.00% |
SO | -0.43% | $100.85B | +29.32% | 3.14% |
SWX | -0.44% | $5.16B | -5.00% | 3.47% |
CRVO | 0.46% | $79.63M | -59.69% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROIV | 52.42% | $7.20B | -3.26% | 0.00% |
KYMR | 43.76% | $1.78B | -30.57% | 0.00% |
RCKT | 43.60% | $711.22M | -75.04% | 0.00% |
DNLI | 41.77% | $1.97B | -33.88% | 0.00% |
DNTH | 41.65% | $582.75M | -38.96% | 0.00% |
IOVA | 40.33% | $1.09B | -76.53% | 0.00% |
CRNX | 39.22% | $3.12B | -27.92% | 0.00% |
IDYA | 38.65% | $1.43B | -61.48% | 0.00% |
VSH | 38.57% | $2.16B | -29.40% | 2.53% |
ACLX | 37.85% | $3.60B | -2.06% | 0.00% |
CLDX | 37.83% | $1.20B | -56.41% | 0.00% |
PLRX | 37.65% | $82.67M | -90.88% | 0.00% |
OCUL | 37.49% | $1.17B | -15.65% | 0.00% |
RCUS | 37.14% | $830.85M | -57.52% | 0.00% |
CRSP | 36.60% | $2.92B | -50.09% | 0.00% |
ARWR | 36.53% | $1.75B | -54.89% | 0.00% |
IONS | 36.26% | $4.80B | -31.34% | 0.00% |
KN | 36.18% | $1.33B | -5.82% | 0.00% |
RVMD | 35.64% | $6.57B | +11.62% | 0.00% |
IMNM | 35.47% | $585.18M | -69.56% | 0.00% |
Current Value
$17.061 Year Return
Current Value
$17.061 Year Return